UC San Francisco is hosting a Precision Public Health Summit, a partnership with the White House and the Bill & Melinda Gates Foundation, to discuss how precision medicine approaches can be successfully applied in the public health arena to improve population health and equity.

The two-day summit on June 6 and 7 will focus on the first 1,000 days, a critically important developmental period in infants and children. Experts from around the country will explore how big data can be leveraged to ensure that all children, no matter their circumstance or where they live, have the best opportunity to survive and thrive.

Members of the UCSF community are invited to watch the live stream on the first day of the summit, featuring speeches by Susan Desmond-Hellmann, MD, MPH, chief executive officer of the Gates Foundation and UCSF Chancellor emerita, and Claudia Williams, senior advisor at the White House Office of Science and Technology Policy.

Other topics include taking action to prevent neonatal morbidity, addressing early childhood and adversity and building health data ecosystems and emerging technologies. You can view the live stream and the full agenda here.

UCSF Chancellor Sam Hawgood, MBBS, who has made advancing precision medicine a priority because it is central to the University’s overarching institutional vision, will provide opening remarks.

The invitation-only event at the Rutter Center at UCSF Mission Bay will bring together about 150 of the nation’s foremost thought leaders in sectors including health, public policy, government, technology, industry, community and philanthropy.

Precision medicine aims to collect, connect and apply vast amounts of scientific research data and information about our health – from the basic molecular understanding of disease to clinical, environmental, psychosocial and mobile lifestyle data – to understand why individuals respond differently to treatments and help guide more precise and predictive medicine and health worldwide.

For more information about UCSF’s role in advancing precision medicine, visit the microsite.